Vion Pharmaceuticals, Inc. | Home

Home

	ABOUT VION		PRODUCTS & PIPELINE		CLINICAL TRIALS		INVESTOR RELATIONS

	WHAT'S NEW Vion Conference Call Vion Announces Initiation of Clinical Trial of Cloretazine® (VNP40101M) in Combination with Cytarabine Vion To Appeal Nasdaq Delisting Vion to Host Conference Call To Discuss 2008 First Quarter Financial Results Vion Reports 2008 First Quarter Results Vion Files Plan With Nasdaq Vion Receives Nasdaq Notice Vion Reports 2007 Fourth Quarter and Year-End Results Vion Regains NASDAQ Listing Compliance Vion to Implement a One-for-Ten Reverse Stock Split Vion Pays Interest on 7.75% Convertible Senior Notes Vion Holds Special Meeting of Stockholders Vion Adds William Hahne, M.D. to Senior Management Team Vion Announces FDA Lift of Clinical Hold on Phase III Study of Cloretazine® (VNP40101M) and Cytarabine in Relapsed AML Vion Presents Preliminary Data from its Pivotal Phase II Trial of Cloretazine® (VNP40101M) in Acute Myelogenous Leukemia at ASH Annual Meeting ASH Poster on Cloretazine® (VNP40101M) in Elderly De Novo Poor-Risk AML Vion Announces Initiation of Clinical Trial of Cloretazine® (VNP40101M) in Combination with Stem Cell Transplantation More News ->		Advancing New Cancer Therapies Vion Pharmaceuticals, Inc. is developing novel agents for the treatment of cancer. We have two small molecule anticancer compounds under evaluation in human clinical trials. Our potential product, Cloretazine® (VNP40101M) is being evaluated for the treatment of acute myelogenous leukemia (AML), in a pivotal Phase 2 trial in elderly de novo poor-risk AML. In addition, clinical trials of Cloretazine® (VNP40101M) are underway in brain tumors in combination with temzolomide and in advanced hematologic malignancies in combination with hematopoietic cell transplantation. Our second potential product, Triapine®, is being evaluated in trials sponsored by the National Cancer Institute.
			Vion is proud to be the official statewide sponsor of the Connecticut Leukemia & Lymphoma Society's annual Light the Night Campaign Vion is proud to sponsor the National Marrow Donor Program of New England to participate in local marrow drives.